BOSTON – Sept. 4, 2024 – Dr. Melissa Hunter-Ensor, co-chair of the Patents and Innovation Strategies Group of global law firm Greenberg Traurig, LLP, was named a 2024 “Go To Healthcare/Life Sciences Lawyer” by Massachusetts Lawyers Weekly. She and her fellow honorees are featured in the publication’s Aug. 19 edition. Hunter-Ensor also received this recognition in 2022.
“Go To” Lawyers are nominated by their peers and chosen by a panel from Massachusetts Lawyers Weekly. Honorees are selected for demonstrating in-depth knowledge in their field and deep experience with a record of success, according to the publication.
“Melissa's exceptional experience and dedication have bolstered the firm’s patent practice and also advanced the fields of life sciences and health care. This recognition reflects her capabilities and leadership, and reinforces Greenberg Traurig's commitment to providing top-tier life sciences legal counsel. We congratulate Melissa on this well-deserved honor," Boston office Co-Managing Shareholders David J. Dykeman and Terence P. McCourt said in a joint statement.
Hunter-Ensor focuses her practice on the IP and commercial needs of clients in the life sciences industry, encompassing pharmaceutical, biotechnology, chemical, agricultural, diagnostics, and medical device companies. She has experience representing clients throughout the business cycle, from startups and universities to global pharmaceutical companies, patent portfolio management, and strategic alliances, as well as litigation and pre-litigation strategy. Hunter-Ensor also assists venture capital firms and other investors in assessing the IP risks of target investments and conducts IP patent and licensing due diligence in connection with complex life science technology transactions.